Resultado de búsqueda
Hace 3 días · Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history. Since 2020, the company has committed more than $18 billion to build, upgrade and acquire facilities in the U.S. and Europe . INDIANAPOLIS, May 24, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has more than doubled its investment in its Lebanon, Indiana ...
Hace 5 días · Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases ...
Stock Price Forecast. The 22 analysts with 12-month price forecasts for Eli Lilly stock have an average target of 755.5, with a low estimate of 500 and a high estimate of 1,001. The average target predicts a decrease of -6.43% from the current stock price of 807.43.
Hace 3 días · Eli Lilly and Company (NYSE:LLY) entered into a definitive agreement to acquire POINT Biopharma Global Inc. (NasdaqCM:PNT) from Joe A. McCann, Allan Charles Silber, Neil E. Fleshner and others for approximately $1.4 billion. Oct 05. Eli Lilly: Big Cancer Bet With Point Biopharma Global Purchase
Hace 3 días · INDIANAPOLIS — Eli Lilly and Co. announced Friday plans to more than double the size of the drug-making facility it is building in Boone County. Lilly CEO David Ricks said the additional $5.3 billion investment will help Lilly keep up with demand for its blockbuster weight-loss and diabetes drugs. "We like to think about the potential for ...
Hace 7 horas · Eli Lilly and Company LLY announced that it is more than doubling its investment in its manufacturing site in Lebanon, IN, from $3.7 billion to $9 billion. This increased investment of $5.3 ...
Hace 3 días · Stock analysis for Eli Lilly & Co (LLY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
